{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:16Z","timestamp":1787020876687,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Monkeypox (MPX) is a common zoonotic disease caused by a double-strand DNA MPX virus (MPXV). MPX was considered a sporadic rare disease causing a mild disease with a low capacity to spread among humans. The clinical picture of human MPX highly resembles smallpox, though early lymphadenopathy in human MPX is the distinguishing sign not present in smallpox. The incubation period is 1\u20133\u00a0weeks, and fever, headache, joint pain, myalgia, and nausea for about 3\u00a0days. Skin lesions that appear 1\u20133\u00a0days following fever and lymphadenopathy usually appear simultaneously on the face and periphery. By cross-reactivity and protection, the smallpox vaccine produced 85% protection against infection with Orthopoxviruses, including MPX. Antiviral drugs like tecovirimate and brincidofovir could be effective agents against the development of MPX. MPX epidemics are less reported and described as other life-threatening epidemics, leading to an unclear picture of this disease\u2019s pathogenesis, epidemiology, and management. With the recent wide range of MPX outbreaks, immense research is mandatory to revise the importance of MPX pathogenesis and risk for epidemic development worldwide. Therefore, this critical study aimed to review MPX's pathogenesis, epidemiology, and management with possible repurposed drugs.<\/jats:p>","DOI":"10.1186\/s13568-023-01507-0","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T04:15:09Z","timestamp":1673583309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Monkeypox epidemic at the door: should we remain idly by or prepare strongly?"],"prefix":"10.1186","volume":"13","author":[{"given":"Hayder M.","family":"Al-Kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-7304","authenticated-orcid":false,"given":"Helal F.","family":"Hetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-874X","authenticated-orcid":false,"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"1507_CR1","doi-asserted-by":"publisher","DOI":"10.7326\/M22-1581","author":"A Adalja","year":"2022","unstructured":"Adalja A, Inglesby T (2022) \"A novel international monkeypox outbreak. Ann Intern Med. https:\/\/doi.org\/10.7326\/M22-1581","journal-title":"Ann Intern Med"},{"key":"1507_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00228-6","author":"H Adler","year":"2022","unstructured":"Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, Osborne JC, Rampling T, Beadsworth MB, Duncan CJ, Dunning J (2022) Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(22)00228-6","journal-title":"Lancet Infect Dis"},{"key":"1507_CR3","doi-asserted-by":"publisher","first-page":"7228","DOI":"10.1111\/j.1742-4658.2009.07402.x","volume":"276","author":"J Akhtar","year":"2009","unstructured":"Akhtar J, Shukla D (2009) Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J 276:7228\u20137236","journal-title":"FEBS J"},{"key":"1507_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-7-173","volume":"7","author":"A Alkhalil","year":"2010","unstructured":"Alkhalil A, Hammamieh R, Hardick J, Ichou MA, Jett M, Ibrahim S (2010) Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions. Virol J 7:1\u201319","journal-title":"Virol J"},{"key":"1507_CR5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/bbrj.bbrj_109_20","volume":"4","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Hussien NR, Al-Naimi MS, Al-Buhadily AK, Al-Gareeb AI, Lungnier C (2020) Is ivermectin\u2013azithromycin combination the next step for COVID-19? Biomed Biotechnol Res J 4:101","journal-title":"Biomed Biotechnol Res J"},{"key":"1507_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.642822","volume":"12","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alqarni M, Cruz-Martins N, Batiha G-S (2021a) Pleiotropic effects of tetracyclines in the management of COVID-19: emerging perspectives. Front Pharmacol 12:642822","journal-title":"Front Pharmacol"},{"key":"1507_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102008","volume":"67","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Qusty N, Cruz-Martins N, Batiha G-S (2021b) Sequential doxycycline and colchicine combination therapy in Covid-19: the salutary effects. Pulm Pharmacol Ther 67:102008","journal-title":"Pulm Pharmacol Ther"},{"key":"1507_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-10-61","volume":"10","author":"D Bourquain","year":"2013","unstructured":"Bourquain D, Dabrowski PW, Nitsche A (2013) Comparison of host cell gene expression in cowpox, monkeypox or vaccinia virus-infected cells reveals virus-specific regulation of immune response genes. Virol J 10:1\u201313","journal-title":"Virol J"},{"key":"1507_CR9","first-page":"165","volume":"58","author":"JG Breman","year":"1980","unstructured":"Breman JG, Steniowski MV, Zanotto E, Gromyko AI, Arita I (1980) Human monkeypox, 1970\u201379. Bull World Health Organ 58:165","journal-title":"Bull World Health Organ"},{"key":"1507_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"EM Bunge","year":"2022","unstructured":"Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R (2022) The changing epidemiology of human monkeypox: a potential threat? A systematic review. PLoS Negl Trop Dis 16:e0010141","journal-title":"PLoS Negl Trop Dis"},{"key":"1507_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/pharmaceutics13020209","volume":"13","author":"I-J Choi","year":"2021","unstructured":"Choi I-J, Hye-Ran Cha Su, Hwang J, Baek S-K, Lee JM, Choi S-O (2021) Live vaccinia virus-coated microneedle array patches for smallpox vaccination and stockpiling. Pharmaceutics 13:209","journal-title":"Pharmaceutics"},{"key":"1507_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1473-3099(03)00856-9","volume":"4","author":"DB Di Giulio","year":"2004","unstructured":"Di Giulio DB, Eckburg PB (2004) Human monkeypox: an emerging zoonosis. Lancet Infect Dis 4:15\u201325","journal-title":"Lancet Infect Dis"},{"key":"1507_CR13","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.3390\/ijms20143427","volume":"20","author":"JK DuShane","year":"2019","unstructured":"DuShane JK, Maginnis MS (2019) Human DNA virus exploitation of the MAPK-ERK cascade. Int J Mol Sci 20:3427","journal-title":"Int J Mol Sci"},{"key":"1507_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003904","volume":"10","author":"CM Filone","year":"2014","unstructured":"Filone CM, Caballero IS, Dower K, Mendillo ML, Cowley GS, Santagata S, Rozelle DK, Yen J, Rubins KH, Hacohen N (2014) The master regulator of the cellular stress response (HSF1) is critical for orthopoxvirus infection. PLoS Pathog 10:e1003904","journal-title":"PLoS Pathog"},{"key":"1507_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1747-0285.2008.00741.x","volume":"72","author":"NS Gandhi","year":"2008","unstructured":"Gandhi NS, Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72:455\u2013482","journal-title":"Chem Biol Drug Des"},{"key":"1507_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa1705688","volume":"379","author":"DW Grosenbach","year":"2018","unstructured":"Grosenbach DW, Honeychurch K, Rose EA, Chinsangaram J, Frimm A, Maiti B, Lovejoy C, Meara I, Long P, Hruby DE (2018) Oral tecovirimat for the treatment of smallpox. N Engl J Med 379:44\u201353","journal-title":"N Engl J Med"},{"key":"1507_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3201\/eid1003.030878","volume":"10","author":"J Guarner","year":"2004","unstructured":"Guarner J, Johnson BJ, Paddock CD, Shieh WJ, Goldsmith CS, Reynolds MG, Damon IK, Regnery RL, Zaki SR, Veterinary Monkeypox Virus Working Group (2004) Monkeypox transmission and pathogenesis in prairie dogs. Emerg Infect Dis 10:426","journal-title":"Emerg Infect Dis"},{"key":"1507_CR18","doi-asserted-by":"publisher","first-page":"14567","DOI":"10.1073\/pnas.0800589105","volume":"105","author":"E Hammarlund","year":"2008","unstructured":"Hammarlund E, Dasgupta A, Pinilla C, Norori P, Fr\u00fch K, Slifka MK (2008) Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation. Proc Natl Acad Sci 105:14567\u201314572","journal-title":"Proc Natl Acad Sci"},{"key":"1507_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106201","author":"WS Ho","year":"2022","unstructured":"Ho WS, Zhang R, Tan YL, Chai CL (2022) COVID-19 and the promise of small molecule therapeutics: are there lessons to be learnt? Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2022.106201","journal-title":"Pharmacol Res"},{"key":"1507_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.virol.2014.06.039","volume":"464","author":"LJ Hughes","year":"2014","unstructured":"Hughes LJ, Goldstein J, Pohl J, Hooper JW, Lee Pitts R, Townsend MB, Bagarozzi D, Damon IK, Karem KL (2014) A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27. Virology 464:264\u2013273","journal-title":"Virology"},{"key":"1507_CR21","first-page":"e00927","volume":"6","author":"CL Hutson","year":"2021","unstructured":"Hutson CL, Kondas AV, Mauldin MR, Doty JB, Grossi IM, Morgan CN, Ostergaard SD, Hughes CM, Nakazawa Y, Kling C (2021) Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. Msphere 6:e00927-e1020","journal-title":"Msphere"},{"key":"1507_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/jmv.25348","volume":"91","author":"AI Kabuga","year":"2019","unstructured":"Kabuga AI, El Zowalaty ME (2019) A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria. J Med Virol 91:533\u2013540","journal-title":"J Med Virol"},{"key":"1507_CR23","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3390\/biomedicines9121780","volume":"9","author":"O Kaynarcalidan","year":"2021","unstructured":"Kaynarcalidan O, Mascaraque SM, Drexler I (2021) Vaccinia virus: from crude smallpox vaccines to elaborate viral vector vaccine design. Biomedicines 9:1780","journal-title":"Biomedicines"},{"key":"1507_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-44259-0","volume-title":"Polymer nanocomposites based on silver nanoparticles","author":"HM Lal","year":"2021","unstructured":"Lal HM, Uthaman A, Thomas S (2021) \u2019Silver nanoparticle as an effective antiviral agent. In: Lal HM, Uthaman A, Thomas S (eds) Polymer nanocomposites based on silver nanoparticles. Springer, Cham"},{"key":"1507_CR25","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","volume":"86","author":"AM Likos","year":"2005","unstructured":"Likos AM, Sammons SA, Olson VA, Michael Frace A, Li Yu, Olsen-Rasmussen M, Davidson W, Galloway R, Khristova ML, Reynolds MG (2005) A tale of two clades: monkeypox viruses. J Gen Virol 86:2661\u20132672","journal-title":"J Gen Virol"},{"key":"1507_CR26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1021\/acsinfecdis.9b00425","volume":"6","author":"Y-P Lin","year":"2020","unstructured":"Lin Y-P, Yanlei Yu, Marcinkiewicz AL, Lederman P, Hart TM, Zhang F, Linhardt RJ (2020) Non-anticoagulant heparin as a pre-exposure prophylaxis prevents lyme disease infection. ACS Infect Dis 6:503\u2013514","journal-title":"ACS Infect Dis"},{"key":"1507_CR27","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1128\/JCM.40.8.2919-2921.2002","volume":"40","author":"H Meyer","year":"2002","unstructured":"Meyer H, Perrichot M, Stemmler M, Emmerich P, Schmitz H, Varaine F, Shungu R, Tshioko F, Formenty P (2002) Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. J Clin Microbiol 40:2919\u20132921","journal-title":"J Clin Microbiol"},{"key":"1507_CR28","doi-asserted-by":"publisher","first-page":"764","DOI":"10.15585\/mmwr.mm7123e1","volume":"71","author":"FS Minhaj","year":"2022","unstructured":"Minhaj FS, Ogale YP, Whitehill F, Schultz J, Foote M, Davidson W, Hughes CM, Wilkins K, Bachmann L, Chatelain R (2022) Monkeypox outbreak\u2014nine states, May 2022. Morb Mortal Wkly Rep 71:764","journal-title":"Morb Mortal Wkly Rep"},{"key":"1507_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3201\/eid1902.121220","volume":"19","author":"Y Nakazawa","year":"2013","unstructured":"Nakazawa Y, Emerson GL, Carroll DS, Zhao H, Li Y, Reynolds MG, Karem KL, Olson VA, Lash RR, Davidson WB, Smith SK (2013) Phylogenetic and ecologic perspectives of a monkeypox outbreak, southern Sudan, 2005. Emerg Infect Dis 19:237","journal-title":"Emerg Infect Dis"},{"key":"1507_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/DDDT.S3687","volume":"4","author":"A Nalca","year":"2010","unstructured":"Nalca A, Zumbrun EE (2010) ACAM2000\u2122: the new smallpox vaccine for United States Strategic National Stockpile. Drug Des Dev Ther 4:71","journal-title":"Drug Des Dev Ther"},{"key":"1507_CR31","unstructured":"Nia Z, Bragazzi NL, Wu J, Kong JD (2022) A twitter dataset for monkeypox. SSRN"},{"key":"1507_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fpubh.2018.00241","volume":"6","author":"N Sklenovska","year":"2018","unstructured":"Sklenovska N, Van Ranst M (2018) Emergence of monkeypox as the most important orthopoxvirus infection in humans. Front Public Health 6:241","journal-title":"Front Public Health"},{"key":"1507_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/biom11010029","volume":"11","author":"H Sodhi","year":"2020","unstructured":"Sodhi H, Panitch A (2020) \"Glycosaminoglycans in tissue engineering: a review. Biomolecules 11:29","journal-title":"Biomolecules"},{"key":"1507_CR34","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1128\/JVI.02089-12","volume":"87","author":"MB Townsend","year":"2013","unstructured":"Townsend MB, Keckler MS, Patel N, Davies DH, Felgner P, Damon IK, Karem KL (2013) Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations. J Virol 87:900\u2013911","journal-title":"J Virol"},{"key":"1507_CR35","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1086\/498155","volume":"41","author":"RA Weinstein","year":"2005","unstructured":"Weinstein RA, Nalca A, Rimoin AW, Bavari S, Whitehouse CA (2005) Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis 41:1765\u20131771","journal-title":"Clin Infect Dis"},{"key":"1507_CR36","volume-title":"Laboratory testing for the monkeypox virus: interim guidance, 23 May 2022","author":"World Health Organization","year":"2022","unstructured":"World Health Organization (2022) Laboratory testing for the monkeypox virus: interim guidance, 23 May 2022. World Health Organization, Geneva"},{"key":"1507_CR37","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3201\/eid2406.180017","volume":"24","author":"A Yinka-Ogunleye","year":"2018","unstructured":"Yinka-Ogunleye A, Aruna O, Ogoina D, Aworabhi N, Eteng W, Badaru S, Mohammed A, Agenyi J, Etebu EN, Numbere TW, Ndoreraho A (2018) \u2019Reemergence of human monkeypox in Nigeria, 2017. Emerg Infect Dis 24:1149","journal-title":"Emerg Infect Dis"},{"key":"1507_CR38","doi-asserted-by":"publisher","first-page":"6174","DOI":"10.1016\/j.vaccine.2021.09.001","volume":"39","author":"T Yoshikawa","year":"2021","unstructured":"Yoshikawa T (2021) Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers. Vaccine 39:6174\u20136181","journal-title":"Vaccine"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-023-01507-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13568-023-01507-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-023-01507-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T12:33:58Z","timestamp":1701693238000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-023-01507-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1507"],"URL":"https:\/\/doi.org\/10.1186\/s13568-023-01507-0","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"25 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}